Nasya

Place in the classical texts

The Charak Samhita online wiki, a reviewed resource on the classical text, describes nasya as one of the five purification procedures of panchakarma, in which medicines are instilled through the nostrils for diseases of the head and associated structures. It points to the Charaka Samhita, Siddhi Sthana chapter 9, for the classification of nasya into types, to Sutra Sthana chapter 5 for seasonal and preventive use, and to the Ashtanga Hridaya, Sutra Sthana chapter 20, for an overview and for the indications and contraindications of the daily form.

A 2026 consensus paper from India's Central Council for Research in Ayurvedic Sciences makes a similar point, noting that the classical texts advocate patient selection and administration of the five panchakarma therapies under the strict supervision of qualified physicians. The authors add that the texts present these procedures as Sanskrit verses that are often not interpreted adequately and are practiced inconsistently across settings. The sources reviewed here do not date the texts; the Ayurveda page on Machipedia covers how their dating is discussed.

Modern efforts to describe the procedure

The same 2026 paper reports that the Council selected the higher-quantity form of nasya as the first panchakarma procedure for which to develop clinical practice guidance. A panel of nine registered Ayurveda practitioners, each with more than ten years of experience, rated draft statements in two rounds, and consensus was reached on 63 best practice statements. The authors chose the title clinical consensus statements rather than guideline because the published scientific evidence was limited, and they state that the statements do not apply to other variants of nasya or to ordinary nasal drops.

Readers can find the wider system on the Ayurveda page, the group of five procedures on the Panchakarma page, the related enema procedure on the Basti page, and the daily routine in which a light form of nasya is placed on the Dinacharya page. The posture and breathing practices that are often taught alongside Ayurveda are covered on the Yoga page.

Meaning of the term and its two main forms

The Charak Samhita online wiki explains the word nasya as meaning something belonging to or being in the nose. It distinguishes two forms by the quantity administered: pratimarsha, a low-quantity form that the page describes as suitable for a daily regimen, and marsha, a higher-quantity form given as an oil or in paste form. English-language abstracts also use the term errhine therapy, and clinical papers use nasya karma for the procedure.

The 2026 consensus paper defines its subject as a therapy in which medicines, mainly with an oil base, are instilled in the nose in a comparatively higher quantity, and it notes that the classical unit used to measure the quantity is often wrongly equated with a single drop. The paper says that its statements are not applicable to other forms of nasya.

Names that are easily confused

A search for the name alone returns an unrelated item. A 2013 placebo-controlled trial of 20 people with house dust mite allergy tested a commercial barrier nasal spray sold under the name Nasya/Prevalin in a single-dose allergen challenge, and reported fewer nasal symptoms at some time points than saline. The abstract describes a drug-free spray, not the Ayurvedic procedure, so its result says nothing about nasya as practiced in Ayurveda and is not used as evidence on this page.

Ayurvedic papers also use several Sanskrit condition names alongside nasya, for example ardita for facial paralysis, pratishyaya for rhinitis and sinusitis, and ardhavabhedaka for a migraine-like headache. These are the tradition's own categories, and the trials discussed below map them to modern diagnoses in different ways.

How the procedure is described in general terms

Ayurvedic sources present nasya as a clinic-based procedure in which a physician selects the patient and the medicine, prepares the patient beforehand, administers the medicine through the nostrils and gives care afterward. The 2026 consensus paper organizes its statements into six domains: general matters, preparatory procedures, the main procedure, post-therapy procedures, dosage and quality assurance. The classical rationale it reports is that the nose is the gateway to the head, so that medicine given by this route acts on the head and sense organs and on conditions of the head and neck. This page does not give preparations, quantities or technique.

The Charak Samhita online wiki lists cautions in general terms, including careful selection of patient and drug, patient education, a warm environment and attention to the temperature of the medicine. It states that improper technique can cause complications such as airway irritation, burns from medicine that is too hot, blockage and fainting or fever. These statements come from a text-based reference rather than from clinical studies.

Variability and supervision

The consensus paper describes numerous inconsistencies in current practice across patient selection, medication, administration method and follow-up care, and a scoping review it cites found few published studies with limited descriptions of procedural details. Its panel strongly agreed that the procedure should be given only under the supervision of a qualified Ayurveda physician, that staff should be trained in basic life support, and that sterilization and sanitization measures should be strictly implemented.

Pratimarsha, the daily lighter form, is described by the Charak Samhita online wiki as part of the regimen for each day and season. That description is from the classical text as summarized by the wiki, and the trials reviewed on this page concern supervised clinical courses rather than the daily form.

Uses described by the tradition

According to the Charak Samhita online wiki, nasya is indicated for diseases of the head and the structures around it, and the 2026 consensus paper says the texts describe it as especially relevant to the head and neck region, with tremor disorders of the head given as one example. The same paper observes that selection criteria have not been investigated thoroughly and that modern clinical conditions need careful interpretation against the classical indications.

The wiki also describes seasonal and preventive use, and a daily form that adherents place in the routine regimen. These are statements of what the tradition holds, not findings from controlled studies.

Conditions studied in modern papers

Published studies have examined nasya, usually inside a larger Ayurvedic treatment plan, in facial paralysis, chronic sinusitis, migraine, cervical spondylosis and allergic rhinitis. A 2022 narrative review of Ayurveda for migraine, a 2023 systematic review of Ayurveda for chronic rhinosinusitis and a 2016 systematic review of nasal oil instillation for facial paralysis frame these conditions in Ayurvedic terms. Listing a condition here describes what has been studied, not what the procedure is established to do.

Systematic reviews

A 2016 Joanna Briggs Institute systematic review searched many databases for studies of oil-based nasal instillation in adults with facial paralysis. Only two small pseudo-randomized studies met the criteria, with about 20 participants in one and 15 per group in the other. Different interventions precluded meta-analysis, and the authors report low-level evidence favoring nasal oil instillation, no study comparing it with conventional treatment, and that no strong conclusions can be drawn because of the number, size and quality of studies.

A 2023 systematic review in chronic rhinosinusitis found 13 studies of Ayurvedic treatment that used oral herbal medicines, nasal instillation and steam inhalation, alone or combined. All 13 concluded that symptoms improved, but all had significant risk of bias from design and statistical methods, and the authors state that a definitive recommendation is not possible. Because the treatments were combined, the review does not isolate the effect of nasya.

Individual trials

In migraine, a double-blind randomized trial of 90 patients compared the same medicated oil prepared at two viscosities for 14 days, with follow-up at 15 and 45 days. Both groups improved on the Migraine Disability Assessment score, the medium-viscosity group improved more, and no adverse event was noticed. The abstract describes no inactive or no-treatment comparison, so it does not show that the improvement exceeds what would occur without treatment. A 2022 narrative review of Ayurveda for migraine found 12 clinical studies, six of them randomized, that mostly used panchakarma procedures, and noted small samples, short follow-up and weak outcome measures.

In cervical spondylosis, a 2012 randomized trial at an Ayurvedic college hospital reported that adding nasya to a course of other Ayurvedic treatment produced more improvement than that course alone. In chronic sinusitis, a 2010 trial registered 37 patients in three groups, of whom 31 completed treatment, and reported marked improvement in a majority of those given a powder form of nasya. Both are small, from Ayurvedic institutions, and the abstracts read describe no blinded or inactive comparison.

For allergic rhinitis, the sources found are a trial protocol for an open-label randomized comparison of an Ayurvedic regimen that includes nasya with a corticosteroid nasal spray, with 90 participants planned per group. No results from it were located.

Limits of the evidence

Searches of PubMed on 19 October 2026 for nasya with Ayurveda returned 58 records, and a title and abstract search for nasya with migraine returned four. No sham-controlled or blinded trial with an inactive comparator of nasya alone was found. In most trials nasya was given with other treatments, so its separate contribution cannot be estimated. The consensus paper adds that published literature was limited and that expert opinion and classical texts are not graded as high-quality evidence.

Adverse events reported

Reporting of harms is sparse. A 2023 case report from a national Ayurveda research council described a 23-year-old woman admitted for refractive error and migraine who developed fever within hours of a nasya session, rising to high grade, which resolved after an antipyretic. The authors scored the event as probably related to nasya using the Naranjo scale, called adverse effects of nasya under-reported, and recommended caution.

The classical reference summarized by the Charak Samhita online wiki lists airway irritation, burns, blockage, fainting and fever as consequences of improper technique. The sources reviewed for this page do not report nasal bleeding, mucosal injury, sinus complications or infection from home-prepared products, and the absence of reports should not be read as evidence that these cannot occur.

Oil in the airway

Case reports from outside the Ayurvedic setting show why oil in the nose is a concern. A 2019 report described exogenous lipoid pneumonia in an adult after chronic use of paraffin oil nasal drops, and a 1997 series from south-western Saudi Arabia described five children aged 4 to 72 months with lipoid pneumonia after olive oil was put into the nose in a lying position, a practice used for nasal congestion. These involve other oils and settings and are not reports of nasya, and they do not establish how often this happens, but they show that aspiration of oil can cause lung disease that did not respond to antibiotics in the series.

Who is advised against it

The Charak Samhita online wiki lists pregnant women, women soon after delivery, the very old, the very young, and people who are tired, worried, unconscious, hungry or thirsty among those for whom nasya is contraindicated. It also lists acute rhinitis, breathing difficulty, cough and acute fever, and the period just after other purification procedures, a head bath or a meal. The consensus paper recommends a fitness assessment that takes contemporary diagnoses into account. The sources reviewed do not address recent surgery specifically, and the National Center for Complementary and Integrative Health advises people not to delay seeing a conventional provider and to speak with a provider during pregnancy. This page is not a substitute for medical care.

Training and standards

The consensus paper's expert panel consisted of registered Ayurveda practitioners in India, and it names the Ministry of Ayush, the Central Council for Research in Ayurvedic Sciences and the National Commission for Indian Systems of Medicine as stakeholders for dissemination. The World Health Organization published updated benchmarks for the training of Ayurveda in 2022, which set minimum criteria for training and describe competency-based content and structure. NCCIH states that Ayurvedic practice and education are not significantly regulated in the United States.